Wang, Chao, et al. (2020)  Case series  Four patients with mild or severe COVID-19 improved after using lopinavir/ritonavir combination.    Three out of four patients improved clinically, especially their pneumonia-related symptoms, whereas others also showed significant improvement. More studies, however, are needed to establish their efficacy.